CASI Pharmaceuticals CASI

$ 2.65 -5.02%

Quarterly report 2022-Q3
added 11-14-2022

CASI Pharmaceuticals Income Statement 2011-2024 | CASI

Annual Income Statement CASI Pharmaceuticals

	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Market Cap	1.09 B	371 M	285 M	300 M	255 M	74.3 M	35 M	45.5 M	49.9 M	39.6 M	28.2 M
Shares	136 M	110 M	95.9 M	84.8 M	61.5 M	55.9 M	32.4 M	28.6 M	26.1 M	19.1 M	11.8 M
Historical Prices	8.4	24.6	17.7	32.8	34.6	14.2	7.9	16.2	18.9	29.5	20.7
Net Income	-36.7 M	-48.3 M	-46 M	-27.5 M	-10.8 M	-9.45 M	-7.21 M	-26.2 M	-5.74 M	-14.5 M	-4.56 M
Revenue	30.2 M	15.1 M	4.13 M	-	-	-	47.7 K	23.7 K	-	669 K	1.94 M
Cost of Revenue	12.6 M	9.51 M	3.94 M	-	-	-	-	-	-	-	-
Gross Profit	17.6 M	5.63 M	196 K	-	-	-	41.4 K	16.3 K	-	669 K	1.94 M
Operating Income	-41.8 M	-51.5 M	-47 M	-27.2 M	-	-	-	-	-	-	-
Interest Expense	2.9 K	3.1 K	5.6 K	7.5 K	7.5 K	-26.1 K	-81.5 K	-26.6 K	1.66 K	10 M	-
EBITDA	-41.4 M	-30.1 M	-37.8 M	-24.8 M	-10.6 M	-9.35 M	-7.08 M	-6.46 M	-5.72 M	-4.48 M	-4.53 M
Operating Expenses	-	38.9 M	40.2 M	26.5 M	10.8 M	9.42 M	7.19 M	6.52 M	5.74 M	5.17 M	6.51 M
General and Administrative Expenses	23.8 M	19.7 M	27.3 M	18 M	3.16 M	4.78 M	3.12 M	3.76 M	2.99 M	2.8 M	3.05 M

All numbers in USD currency

Quarterly Income Statement CASI Pharmaceuticals

	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Shares	-	13.6 M	13.6 M	138 M	14 M	14 M	14 M	125 M	124 M	118 M	101 K	98.8 K	97.8 M	95.9 K	95.7 K	95.6 K	95.3 M	81.5 K	86 M	71.2 M	69.8 M	60.2 M	60.2 M	60.2 M	-	49.2 M	42.9 M	40.2 M	-	32.4 M	32.4 M	32.4 M	-	27.8 M	27 M	27 M	27.1 M	27 M	27 M	23.4 M	22.6 M	22.5 M	19 M	12.2 M	12.2 M	12 M	11.5 M	12.2 M
Net Income	-	-5.2 M	-7.68 M	-8.6 M	-	-10.2 M	-6.95 M	-13.9 M	-	-17 M	-8.69 M	-8.44 M	-	-9.89 M	-15.5 M	-8.18 M	-	-8.76 M	-5.86 M	-3.59 M	-	-1.61 M	-2.41 M	-1.7 M	-	-1.69 M	-3.29 M	-1.79 M	-	-1.6 M	-2.1 M	-1.8 M	-	-21.5 M	-1.62 M	-1.45 M	-	-1.44 M	-1.85 M	-1.14 M	-	-1.19 M	-10.5 M	-2.53 M	-	-1.31 M	-1.66 M	-2.6 M
Revenue	-	10.2 M	8.57 M	9.06 M	-	8.11 M	7.16 M	5.74 M	-	4.24 M	2.67 M	3.41 M	-	2.79 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	24 K	23.7 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	8.85 K	-
Cost of Revenue	-	4.25 M	3.55 M	3.76 M	-	3.42 M	2.98 M	2.36 M	-	1.83 M	2.52 M	3.21 M	-	2.65 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	5.97 M	5.02 M	5.3 M	-	4.7 M	4.18 M	3.38 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income	-	-6.35 M	-7.75 M	-7.29 M	-	-6.89 M	-7.98 M	-15.6 M	-	-18.7 M	-8.89 M	-8.77 M	-	-10.6 M	-15.8 M	-8.32 M	-	-8.71 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest Expense	-	11 K	11 K	38 K	-	487 K	33 K	1 M	-	1.2 K	700	190 K	-	414 K	320 K	49 K	-	11 K	13.1 K	6.73 K	-	-546	-72	142	-	-5.61 K	-8.76 K	-8.77 K	-	-24.3 K	-24.3 K	-24.2 K	-	-2.93 K	129	384	-	408	443	-390	-	-	9.17 M	876 K	-	-	-	-
EBITDA	-	-5.79 M	-7.64 M	-7.2 M	-	-6.5 M	-7.67 M	-15.4 M	-	-18.3 M	-8.61 M	-8.62 M	-	-10.1 M	-15.2 M	-8.19 M	-	-8.46 M	142 K	65.8 K	-	69.4 K	37.9 K	18.5 K	-	48 K	32.5 K	19 K	-	50.8 K	33.2 K	16.5 K	-	32.7 K	19.2 K	6.53 K	-	12.9 K	9.04 K	4.66 K	-	15.1 K	9.38 K	4.23 K	-	33.6 K	23.7 K	12.1 K
Operating Expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
General and Administrative Expenses	-	4.85 M	5.52 M	5.32 M	-	5.26 M	5.49 M	5.5 M	-	5.35 M	4.08 M	4.06 M	-	7.98 M	6.98 M	5.71 M	-	6.9 M	4.04 M	1.3 M	-	626 K	691 K	644 K	-	677 K	1.91 M	765 K	-	674 K	858 K	925 K	-	1.15 M	892 K	891 K	-	663 K	1.02 M	630 K	-	565 K	602 K	1.1 M	-	557 K	720 K	1.25 M

All numbers in USD currency